tradmap

BBNX Earnings Beta Bionics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$9 -$4 $0 2023 2024 2025
EPS
Revenue (annual)
$0 $50M $100M 2023 2024 2025
Revenue
Net income (annual)
-$73M -$37M $0 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$6 -$3 $0 Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26
EPS
Revenue (quarterly)
$0 $16M $32M Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue
Net income (quarterly)
-$29M -$14M $0 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Net income

Reported EPS history

1–11 of 11
Q2 20262026-06-30-1.022026-07-2910-Q
Q1 20262026-03-31-0.492026-04-2110-Q
FY 20252025-12-31-1.812026-02-2410-K
Q3 20252025-09-30-1.522025-10-2810-Q
Q2 20262025-06-30-1.232026-07-2910-Q
Q1 20262025-03-31-0.932026-04-2110-Q
FY 20252024-12-31-8.602026-02-2410-K
Q3 20252024-09-30-5.862025-10-2810-Q
Q2 20252024-06-30-4.442025-07-2910-Q
Q1 20252024-03-31-2.072025-05-0610-Q
FY 20242023-12-31-8.312025-03-2510-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.